GLO1 and diabetic kidney disease: In summary, by manipulating GLO1 activity in Apoe−/− mice, we have demonstrated distinct differences in the diabetes‐induced metabolic changes that result in diabetic nephropathy and diabetic atherosclerosis, respectively.